PUBLIC CONTRACT · 2023
Pc 2023010003 1036723, ceftriaxone 1000MG po sol inj fr IV/im, carboplastina 10MG/ml sol inj fr 45ML IV
- Contract value
- €5,337.00
- Signed on
- 17 January 2023
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 9812964PUBLISHED SUBJECT
PC 2023010003 1036723, CEFTRIAXONE 1000MG PO SOL INJ FR IV/IM, CARBOPLASTINA 10MG/ML SOL INJ FR 45ML IV
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Porto, Porto
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- HIKMA FARMACEUTICA (PORTUGAL), LDA · Tax ID 502266791
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €5,337.00
- Procedure base price
- €5,337.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 22 February 2023
- Award date
- 17 January 2023
- Signing date
- 17 January 2023
- Performance period
- 20 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Monofator
- CPV code
- 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
- Legal basis
- Artigo 24.º, n.º 1, alínea c) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6354636
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.